Skip to main content

Table 1 Characteristics of the included literature

From: Meta-analysis of the efficacy and safety of OLIF and TLIF in the treatment of degenerative lumbar spondylolisthesis

First author

Year

Research design method

Gender (N)

OLIF/TLIF

Nos

Risk of biasassessment

Males

Females

Sample size (N)

Average age (year)

Average follow-up time (months)

Hiromitsu Takaoka

2021

Retrospective study

63

80

65/78

66 ± 12 / 71 ± 9

64.0 ± 16.2/53.0 ± 13.0

7

 

Guangqing Li

2022

Retrospective study

16

56

36/36

58.52 ± 7.26 / 59.88 ± 7.04

43.13 ± 3.24/44.42 ± 4.54

7

 

Renjie-Li

2021

Retrospective study

15

48

28/35

57.5 ± 10.4 / 59.3 ± 9.86

6

7

 

Zhongyou Zeng

2022

Prospective study

33

82

59/56

56 ± 8 / 58 ± 6

27.0 ± 3.4

7

 

Tairui Guo

2022

Retrospective study

30

24

25/29

56.5 ± 10.2

13. 9 ± 1. 9

5

 

Kai Huang

2019

Retrospective study

33

23

26/30

60. 33 ± 4. 88 / 61. 04 ± 4. 84

24

7

 

Hongjun Lei

2020

Randomized controlled trial

34

26

30/30

57.2 ± 4.5 / 56.8 ± 4.3

6

\

Low risk

Renjie Li

2021

Retrospective study

13

55

33/35

59.7 + 8.5 / 58.6 + 7.58

6

7

 

Weibin Tie

2022

Retrospective study

14

29

20/23

59.75 ± 9.25 / 58.78 ± 8.06

22.70 ± 6.51

7

 

Shengdong Wang

2021

Retrospective study

23

45

33/35

62.76 ± 6.83 / 58.51 ± 6.84

12

7

 

Qiang Zhang

2019

Retrospective study

13

17

15/15

50.2 ± 7.6 / 51.5 ± 6.3

8.5 ± 2.3

7

 

Shengming Wu

2019

Retrospective study

12

21

14/19

60 ± 9 / 55 ± 12

3

7

 

Zhiwei Ye

2020

Retrospective study

19

26

20/25

46.14 ± 9.24 / 47.63 ± 13.28

14.3

7

 

Shiqiang Qin

2023

Retrospective study

11

16

10/17

50.4 ± 7.79 / 61.7 ± 8.51

15.3 ± 3.4

7

Â